dc.contributor.author | Speakman, Mark J. | |
dc.contributor.author | Cornu, Jean-Nicolas | |
dc.contributor.author | Gacci, Mauro | |
dc.contributor.author | Gratzke, Christian | |
dc.contributor.author | Mamoulakis, Charalampos | |
dc.contributor.author | Herrmann, Thomas R. W. | |
dc.contributor.author | Omar, Muhammad Imran | |
dc.contributor.author | Rieken, Malte | |
dc.contributor.author | Tikkinen, Kari A.O. | |
dc.contributor.author | Gravas, Stavros | |
dc.date.accessioned | 2020-06-13T23:07:23Z | |
dc.date.available | 2020-06-13T23:07:23Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Speakman , M J , Cornu , J-N , Gacci , M , Gratzke , C , Mamoulakis , C , Herrmann , T R W , Omar , M I , Rieken , M , Tikkinen , K A O & Gravas , S 2019 , ' What Is the Required Certainty of Evidence for the Implementation of Novel Techniques for the Treatment of Benign Prostatic Obstruction? ' , European Urology Focus , vol. 5 , no. 3 , pp. 351-356 . https://doi.org/10.1016/j.euf.2019.05.014 | en |
dc.identifier.issn | 2405-4569 | |
dc.identifier.other | PURE: 145262069 | |
dc.identifier.other | PURE UUID: aa91cca3-1ea3-4958-ae47-799212d9ec55 | |
dc.identifier.other | Scopus: 85067170269 | |
dc.identifier.other | Mendeley: 7e11a997-fa31-35f7-8418-ed4ee08cd0d4 | |
dc.identifier.other | WOS: 000486154800011 | |
dc.identifier.other | ORCID: /0000-0002-1597-3126/work/63243426 | |
dc.identifier.uri | https://hdl.handle.net/2164/14497 | |
dc.format.extent | 6 | |
dc.language.iso | eng | |
dc.relation.ispartof | European Urology Focus | en |
dc.rights | © 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ | en |
dc.subject | Benign | en |
dc.subject | Certainty of evidence | en |
dc.subject | Core outcomes | en |
dc.subject | Lower urinary tract symptoms | en |
dc.subject | Minimally invasive treatments | en |
dc.subject | Prostatic obstruction | en |
dc.subject | BALLOON DILATATION | en |
dc.subject | TRANSURETHRAL NEEDLE ABLATION | en |
dc.subject | OUTCOMES | en |
dc.subject | HYPERPLASIA | en |
dc.subject | ASSOCIATION | en |
dc.subject | R Medicine (General) | en |
dc.subject | Urology | en |
dc.subject.lcc | R1 | en |
dc.title | What Is the Required Certainty of Evidence for the Implementation of Novel Techniques for the Treatment of Benign Prostatic Obstruction? | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Academic Urology Unit | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Postprint | en |
dc.identifier.doi | https://doi.org/10.1016/j.euf.2019.05.014 | |
dc.date.embargoedUntil | 2020-06-14 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85067170269&partnerID=8YFLogxK | en |
dc.identifier.url | http://www.mendeley.com/research/required-certainty-evidence-implementation-novel-techniques-treatment-benign-prostatic-obstruction | en |
dc.identifier.url | http://pure-ots.abdn.ac.uk:8080/portal/en/researchoutput/what-is-the-required-certainty-of-evidence-for-the-implementation-of-novel-techniques-for-the-treatment-of-benign-prostatic-obstruction(aa91cca3-1ea3-4958-ae47-799212d9ec55).html | en |
dc.identifier.vol | 5 | en |
dc.identifier.iss | 3 | en |